Off-Label Use of Peripheral Paclitaxel Drug-Coated Balloons in Management of Recurrent Coronary In-Stent Restenosis

Mahesh V. Madhavan; Emad Hakemi; Rishi Neeranjun; Hussein Rahim; Shayan Nabavi Nouri; Erin Flattery; Megha Prasad; Michael Collins; Dimitri Karmpaliotis; Ziad A. Ali; Sahil A. Parikh; Torsten Vahl; Amisha Patel; Tamim Nazif; Khady Fall; Akiko Maehara; Martin B. Leon; Ajay J. Kirtane; Jeffrey W. Moses

doi:10.1016/j.jscai.2023.101262

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

While not available for clinical use in the United States, dedicated drug-coated balloons (DCB) are currently under investigation for the management of coronary in-stent restenosis (ISR). Peripheral drug-coated balloons (P-DCB) have been used off-label for coronary ISR. Further data regarding this practice are needed. We aimed to describe outcomes in patients who underwent off-label P-DCB angioplasty for coronary ISR.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Madhavan et al. (2024) studied this question.

synapsesocial.com/papers/68e786f9b6db6435876f98b6 https://doi.org/10.1016/j.jscai.2023.101262

View Full Paper

Ask AI

Bookmark

Share

Off-Label Use of Peripheral Paclitaxel Drug-Coated Balloons in Management of Recurrent Coronary In-Stent Restenosis

Ask about this paper

Abstract

Discussion

Cite This Study

Off-Label Use of Peripheral Paclitaxel Drug-Coated Balloons in Management of Recurrent Coronary In-Stent Restenosis

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading